skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,103  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
Material Type:
Article
Add to My Research

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Blood, 2020-12, Vol.136 (26), p.3033-3040 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020008150 ;PMID: 33367546

Full text available

2
Unexpected parvovirus B19 infection in a patient with multiple myeloma
Material Type:
Article
Add to My Research

Unexpected parvovirus B19 infection in a patient with multiple myeloma

Blood, 2023-09, Vol.142 (11), p.1026-1026 [Peer Reviewed Journal]

2023 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023021561 ;PMID: 37707869

Full text available

3
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
Material Type:
Article
Add to My Research

Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group

The lancet oncology, 2021-03, Vol.22 (3), p.e119-e130 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;info:eu-repo/semantics/openAccess ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30559-3 ;PMID: 33545067

Full text available

4
Myeloma bone disease: from biology findings to treatment approaches
Material Type:
Article
Add to My Research

Myeloma bone disease: from biology findings to treatment approaches

Blood, 2019-04, Vol.133 (14), p.1534-1539 [Peer Reviewed Journal]

2019 American Society of Hematology ;2019 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-11-852459 ;PMID: 30760454

Full text available

5
Multiple myeloma presenting with hepatic light chain deposition
Material Type:
Article
Add to My Research

Multiple myeloma presenting with hepatic light chain deposition

Blood, 2023-05, Vol.141 (19), p.2402-2402 [Peer Reviewed Journal]

2023 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023019997 ;PMID: 37166924

Full text available

6
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies
Material Type:
Article
Add to My Research

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

Blood cancer journal (New York), 2022-02, Vol.12 (2), p.32-32, Article 32 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2044-5385 ;EISSN: 2044-5385 ;DOI: 10.1038/s41408-022-00629-1 ;PMID: 35210399

Full text available

7
An unusual case of a multiple myeloma with thyroid involvement at primary diagnosis
Material Type:
Article
Add to My Research

An unusual case of a multiple myeloma with thyroid involvement at primary diagnosis

Blood, 2023-03, Vol.141 (9), p.1092-1092 [Peer Reviewed Journal]

2023 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2022018243 ;PMID: 36862432

Full text available

8
COVID-19 outcomes in patients with hematologic disease
Material Type:
Article
Add to My Research

COVID-19 outcomes in patients with hematologic disease

Bone marrow transplantation (Basingstoke), 2020-11, Vol.55 (11), p.2180-2184 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 0268-3369 ;EISSN: 1476-5365 ;DOI: 10.1038/s41409-020-0931-4 ;PMID: 32376969

Full text available

9
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
Material Type:
Article
Add to My Research

Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5), p.1089-1100 [Peer Reviewed Journal]

2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-15-1703 ;PMID: 26833121

Full text available

10
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
Material Type:
Article
Add to My Research

Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma

Blood, 2022-01, Vol.139 (1), p.137-142 [Peer Reviewed Journal]

2022 American Society of Hematology ;Copyright © 2022 American Society of Hematology. All rights reserved. 2022 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021013429 ;PMID: 34657156

Full text available

11
European Myeloma Network guidelines for the management of multiple myeloma-related complications
Material Type:
Article
Add to My Research

European Myeloma Network guidelines for the management of multiple myeloma-related complications

Haematologica (Roma), 2015-10, Vol.100 (10), p.1254-1266 [Peer Reviewed Journal]

Copyright© Ferrata Storti Foundation. ;Copyright© Ferrata Storti Foundation 2015 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2014.117176 ;PMID: 26432383

Full text available

12
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma
Material Type:
Article
Add to My Research

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

Blood, 2017-06, Vol.129 (26), p.3452-3464 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-03-773341 ;PMID: 28515094

Full text available

13
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Material Type:
Article
Add to My Research

Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients

Haematologica (Roma), 2015-01, Vol.100 (1), p.107-113 [Peer Reviewed Journal]

Copyright© Ferrata Storti Foundation. ;Copyright© Ferrata Storti Foundation 2015 ;ISSN: 0390-6078 ;ISSN: 1592-8721 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2014.107714 ;PMID: 25344526

Full text available

14
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Material Type:
Article
Add to My Research

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

Journal of clinical oncology, 2019-08, Vol.37 (22), p.1946-1955 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00231 ;PMID: 31188726

Full text available

15
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
Material Type:
Article
Add to My Research

Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

Leukemia, 2021-12, Vol.35 (12), p.3534-3541 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;The Author(s), under exclusive licence to Springer Nature Limited 2021 ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-021-01354-7 ;PMID: 34326466

Full text available

16
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Material Type:
Article
Add to My Research

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

Leukemia, 2021-01, Vol.35 (1), p.31-44 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0887-6924 ;ISSN: 1476-5551 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-020-01016-0 ;PMID: 32814840

Full text available

17
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
Material Type:
Article
Add to My Research

Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus

Advanced materials (Weinheim), 2016-11, Vol.28 (43), p.9573-9580 [Peer Reviewed Journal]

2016 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. ;ISSN: 0935-9648 ;EISSN: 1521-4095 ;DOI: 10.1002/adma.201603463 ;PMID: 27626769

Full text available

18
VTE prophylaxis in multiple myeloma
Material Type:
Article
Add to My Research

VTE prophylaxis in multiple myeloma

Blood, 2022-12, Vol.140 (23), p.2413-2414 [Peer Reviewed Journal]

2022 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2022017517 ;PMID: 36480221

Full text available

19
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis
Material Type:
Article
Add to My Research

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis

Haematologica (Roma), 2022-06, Vol.107 (6), p.1397-1409 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;Copyright© 2022 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2021.279229 ;PMID: 34647444

Full text available

20
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells
Material Type:
Article
Add to My Research

Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells

Haematologica (Roma), 2024-02, Vol.109 (2), p.682-688 [Peer Reviewed Journal]

Copyright© 2024 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.283296 ;PMID: 37675514

Full text available

Results 1 - 20 of 3,103  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,854)

Refine My Results

Creation Date 

From To
  1. Before 1967  (43)
  2. 1967 To 1980  (345)
  3. 1981 To 1994  (464)
  4. 1995 To 2009  (1,005)
  5. After 2009  (1,251)
  6. More options open sub menu

Language 

  1. English  (2,971)
  2. Japanese  (232)
  3. Spanish  (51)
  4. French  (40)
  5. German  (27)
  6. Portuguese  (12)
  7. Russian  (11)
  8. Italian  (7)
  9. Polish  (5)
  10. Chinese  (5)
  11. Norwegian  (4)
  12. Swedish  (2)
  13. Turkish  (2)
  14. Korean  (2)
  15. Czech  (2)
  16. Serbian  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait